Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

MedWellAI (MWAI) Return on Sales (2016 - 2025)

MedWellAI (MWAI) has disclosed Return on Sales for 10 consecutive years, with 1.33% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Sales rose 148.0% to 1.33% in Q4 2025 year-over-year; TTM through Dec 2025 was 1.33%, a 162.0% decrease, with the full-year FY2025 number at 1.39%, changed N/A from a year prior.
  • Return on Sales was 1.33% for Q4 2025 at MedWellAI, down from 0.76% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.7% in Q3 2021 to a low of 508.99% in Q3 2024.
  • A 5-year average of 29.07% and a median of 1.72% in 2022 define the central range for Return on Sales.
  • Peak YoY movement for Return on Sales: tumbled -50041bps in 2024, then surged 50823bps in 2025.
  • MedWellAI's Return on Sales stood at 0.2% in 2021, then crashed by -920bps to 2.06% in 2022, then surged by 90bps to 0.21% in 2023, then tumbled by -1251bps to 2.81% in 2024, then surged by 53bps to 1.33% in 2025.
  • Per Business Quant, the three most recent readings for MWAI's Return on Sales are 1.33% (Q4 2025), 0.76% (Q3 2025), and 2.02% (Q2 2025).